nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—CHRM2—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.0618	0.145	CbGpPWpGaD
Prochlorperazine—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.0263	0.0561	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.0242	0.0517	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.02	0.0427	CcSEcCtD
Prochlorperazine—DRD3—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0185	0.0433	CbGpPWpGaD
Prochlorperazine—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.0176	0.0376	CcSEcCtD
Prochlorperazine—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0171	0.0365	CcSEcCtD
Prochlorperazine—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.017	0.0362	CcSEcCtD
Prochlorperazine—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.0165	0.0351	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.0164	0.035	CcSEcCtD
Prochlorperazine—Metixene—CHRM3—nephrolithiasis	0.016	0.152	CrCbGaD
Prochlorperazine—HTR2C—Monoamine GPCRs—CHRM3—nephrolithiasis	0.016	0.0376	CbGpPWpGaD
Prochlorperazine—DRD3—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0155	0.0364	CbGpPWpGaD
Prochlorperazine—DRD2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0141	0.0332	CbGpPWpGaD
Prochlorperazine—HRH1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0139	0.0326	CbGpPWpGaD
Prochlorperazine—CHRM2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0136	0.032	CbGpPWpGaD
Prochlorperazine—HTR2C—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0135	0.0316	CbGpPWpGaD
Prochlorperazine—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0285	CcSEcCtD
Prochlorperazine—Influenza—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0285	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0263	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.0122	0.026	CcSEcCtD
Prochlorperazine—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.0122	0.026	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0257	CcSEcCtD
Prochlorperazine—DRD2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0119	0.0279	CbGpPWpGaD
Prochlorperazine—HRH1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0117	0.0274	CbGpPWpGaD
Prochlorperazine—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0248	CcSEcCtD
Prochlorperazine—CHRM2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0115	0.0269	CbGpPWpGaD
Prochlorperazine—Aripiprazole—CHRM3—nephrolithiasis	0.0114	0.109	CrCbGaD
Prochlorperazine—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0237	CcSEcCtD
Prochlorperazine—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0225	CcSEcCtD
Prochlorperazine—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0216	CcSEcCtD
Prochlorperazine—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00956	0.0204	CcSEcCtD
Prochlorperazine—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00931	0.0199	CcSEcCtD
Prochlorperazine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00905	0.0193	CcSEcCtD
Prochlorperazine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00896	0.0191	CcSEcCtD
Prochlorperazine—Propiomazine—CHRM3—nephrolithiasis	0.00886	0.0842	CrCbGaD
Prochlorperazine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00878	0.0187	CcSEcCtD
Prochlorperazine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00873	0.0186	CcSEcCtD
Prochlorperazine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00856	0.0183	CcSEcCtD
Prochlorperazine—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00851	0.0182	CcSEcCtD
Prochlorperazine—Chlorprothixene—CHRM3—nephrolithiasis	0.00839	0.0797	CrCbGaD
Prochlorperazine—CHRM2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00837	0.0196	CbGpPWpGaD
Prochlorperazine—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00834	0.0178	CcSEcCtD
Prochlorperazine—DRD3—GPCRs, Other—CHRM3—nephrolithiasis	0.0082	0.0192	CbGpPWpGaD
Prochlorperazine—Cough—Hydrochlorothiazide—nephrolithiasis	0.00813	0.0173	CcSEcCtD
Prochlorperazine—DRD3—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00786	0.0184	CbGpPWpGaD
Prochlorperazine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00776	0.0165	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.0076	0.0162	CcSEcCtD
Prochlorperazine—Oedema—Hydrochlorothiazide—nephrolithiasis	0.0076	0.0162	CcSEcCtD
Prochlorperazine—Methotrimeprazine—CHRM3—nephrolithiasis	0.00758	0.072	CrCbGaD
Prochlorperazine—Promethazine—CHRM3—nephrolithiasis	0.00746	0.0709	CrCbGaD
Prochlorperazine—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00744	0.0159	CcSEcCtD
Prochlorperazine—Loxapine—CHRM3—nephrolithiasis	0.00732	0.0695	CrCbGaD
Prochlorperazine—Quetiapine—CHRM3—nephrolithiasis	0.00714	0.0679	CrCbGaD
Prochlorperazine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.0071	0.0152	CcSEcCtD
Prochlorperazine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00688	0.0147	CcSEcCtD
Prochlorperazine—Desipramine—CHRM3—nephrolithiasis	0.00678	0.0644	CrCbGaD
Prochlorperazine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00678	0.0145	CcSEcCtD
Prochlorperazine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00676	0.0144	CcSEcCtD
Prochlorperazine—Promazine—CHRM3—nephrolithiasis	0.00657	0.0624	CrCbGaD
Prochlorperazine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.0065	0.0139	CcSEcCtD
Prochlorperazine—Clozapine—CHRM3—nephrolithiasis	0.00614	0.0584	CrCbGaD
Prochlorperazine—CHRM2—GPCRs, Other—CHRM3—nephrolithiasis	0.00606	0.0142	CbGpPWpGaD
Prochlorperazine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00604	0.0129	CcSEcCtD
Prochlorperazine—DRD2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00601	0.0141	CbGpPWpGaD
Prochlorperazine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00601	0.0128	CcSEcCtD
Prochlorperazine—CHRM2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00581	0.0136	CbGpPWpGaD
Prochlorperazine—Chlorpromazine—CHRM3—nephrolithiasis	0.00578	0.0549	CrCbGaD
Prochlorperazine—Imipramine—CHRM3—nephrolithiasis	0.00575	0.0546	CrCbGaD
Prochlorperazine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.0056	0.0119	CcSEcCtD
Prochlorperazine—HTR2C—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00553	0.013	CbGpPWpGaD
Prochlorperazine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00538	0.0115	CcSEcCtD
Prochlorperazine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00503	0.0107	CcSEcCtD
Prochlorperazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00494	0.0116	CbGpPWpGaD
Prochlorperazine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00479	0.0102	CcSEcCtD
Prochlorperazine—HRH1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00479	0.0112	CbGpPWpGaD
Prochlorperazine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00479	0.0102	CcSEcCtD
Prochlorperazine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00476	0.0102	CcSEcCtD
Prochlorperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00428	0.0101	CbGpPWpGaD
Prochlorperazine—CHRM2—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.00409	0.00959	CbGpPWpGaD
Prochlorperazine—CHRM2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00409	0.00959	CbGpPWpGaD
Prochlorperazine—HTR2C—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.004	0.00938	CbGpPWpGaD
Prochlorperazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00357	0.00839	CbGpPWpGaD
Prochlorperazine—DRD3—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00356	0.00836	CbGpPWpGaD
Prochlorperazine—HRH1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00346	0.00813	CbGpPWpGaD
Prochlorperazine—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.00341	0.00801	CbGpPWpGaD
Prochlorperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.0031	0.00727	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00309	0.00725	CbGpPWpGaD
Prochlorperazine—DRD3—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00305	0.00716	CbGpPWpGaD
Prochlorperazine—DRD2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00273	0.0064	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—RGS14—nephrolithiasis	0.00269	0.00631	CbGpPWpGaD
Prochlorperazine—HRH1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00268	0.00628	CbGpPWpGaD
Prochlorperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00265	0.00621	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00263	0.00618	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—RGS14—nephrolithiasis	0.00244	0.00573	CbGpPWpGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00234	0.00548	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—RGS14—nephrolithiasis	0.00233	0.00547	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—CHRM3—nephrolithiasis	0.00232	0.00546	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00229	0.00538	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00226	0.0053	CbGpPWpGaD
Prochlorperazine—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.00223	0.00524	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—PTH—nephrolithiasis	0.00213	0.00499	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—RGS14—nephrolithiasis	0.00212	0.00497	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00206	0.00483	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00202	0.00474	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—CHRM3—nephrolithiasis	0.00202	0.00473	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00199	0.00467	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—RGS14—nephrolithiasis	0.00187	0.00439	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—PTH—nephrolithiasis	0.00184	0.00433	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—RGS14—nephrolithiasis	0.00183	0.00431	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—DGKH—nephrolithiasis	0.00182	0.00426	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—RGS14—nephrolithiasis	0.00181	0.00424	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—CHRM3—nephrolithiasis	0.00178	0.00417	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00175	0.0041	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—CHRM3—nephrolithiasis	0.00172	0.00403	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—ADCY10—nephrolithiasis	0.0017	0.00398	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—DGKH—nephrolithiasis	0.00165	0.00387	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—PTH—nephrolithiasis	0.00163	0.00382	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—PTH—nephrolithiasis	0.0016	0.00375	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—DGKH—nephrolithiasis	0.00158	0.0037	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—PTH—nephrolithiasis	0.00157	0.00369	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—ADCY10—nephrolithiasis	0.00147	0.00345	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—RGS14—nephrolithiasis	0.00144	0.00339	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—DGKH—nephrolithiasis	0.00143	0.00336	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—DGKH—nephrolithiasis	0.00139	0.00326	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00136	0.0032	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—DGKH—nephrolithiasis	0.00134	0.00315	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00131	0.00308	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—ADCY10—nephrolithiasis	0.0013	0.00305	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—ADCY10—nephrolithiasis	0.00127	0.00299	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—DGKH—nephrolithiasis	0.00126	0.00296	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—ADCY10—nephrolithiasis	0.00125	0.00294	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—RGS14—nephrolithiasis	0.00125	0.00294	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—DGKH—nephrolithiasis	0.00124	0.00291	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	0.00122	0.00286	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—PTH—nephrolithiasis	0.0012	0.00282	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—CHRM3—nephrolithiasis	0.00119	0.0028	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00114	0.00267	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—RGS14—nephrolithiasis	0.0011	0.00259	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—PTH—nephrolithiasis	0.00109	0.00256	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—RGS14—nephrolithiasis	0.00108	0.00254	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	0.00107	0.0025	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—PTH—nephrolithiasis	0.00104	0.00244	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—CHRM3—nephrolithiasis	0.00103	0.00243	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00101	0.00236	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000987	0.00232	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—DGKH—nephrolithiasis	0.000975	0.00229	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000975	0.00229	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000971	0.00228	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—PTH—nephrolithiasis	0.000946	0.00222	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	0.000919	0.00216	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	0.000913	0.00214	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—PTH—nephrolithiasis	0.000903	0.00212	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000896	0.0021	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	0.000888	0.00208	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	0.000882	0.00207	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000845	0.00198	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—DGKH—nephrolithiasis	0.000845	0.00198	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—PTH—nephrolithiasis	0.000835	0.00196	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—PTH—nephrolithiasis	0.00082	0.00192	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	0.000806	0.00189	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.00077	0.00181	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—DGKH—nephrolithiasis	0.000746	0.00175	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000746	0.00175	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000732	0.00172	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—DGKH—nephrolithiasis	0.000732	0.00172	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	0.00072	0.00169	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00072	0.00169	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CHRM3—nephrolithiasis	0.000705	0.00165	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000686	0.00161	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PTH—nephrolithiasis	0.000644	0.00151	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CHRM3—nephrolithiasis	0.000611	0.00143	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000584	0.00137	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000584	0.00137	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PTH—nephrolithiasis	0.000559	0.00131	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	0.000539	0.00127	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CHRM3—nephrolithiasis	0.000529	0.00124	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	0.000521	0.00122	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000504	0.00118	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PTH—nephrolithiasis	0.000493	0.00116	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PTH—nephrolithiasis	0.000484	0.00114	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PTH—nephrolithiasis	0.000476	0.00112	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000449	0.00105	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000416	0.000976	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000382	0.000896	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000382	0.000896	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000376	0.000883	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—SPP1—nephrolithiasis	0.000324	0.000759	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—SPP1—nephrolithiasis	0.00028	0.000658	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—AQP1—nephrolithiasis	0.000272	0.000638	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SPP1—nephrolithiasis	0.000248	0.000581	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CHRM3—nephrolithiasis	0.000246	0.000577	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SPP1—nephrolithiasis	0.000243	0.000571	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	0.000239	0.000561	CbGpPWpGaD
